Inhibition of matrix metalloproteinases by HIV-1 integrase strand transfer inhibitors

Inhibition of matrix metalloproteinases by HIV-1 integrase strand transfer inhibitors

More than fifteen million women with the human immunodeficiency virus type-1 (HIV-1) infection are of childbearing age world-wide. Due to improved and affordable access to antiretroviral therapy (ART), the number of in utero antiretroviral drug (ARV)-exposed children has exceeded a million and conti...

Full description

Bibliographic Details
Main Authors: Emma G. Foster, Nicholas Y. Palermo, Yutong Liu, Benson Edagwa, Howard E. Gendelman, Aditya N. Bade
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Toxicology
Subjects:
HIV-1
pregnancy
antiretroviral drugs
integrase strand transfer inhibitors
neurodevelopment
drug-induced adverse events
Online Access:https://www.frontiersin.org/articles/10.3389/ftox.2023.1113032/full

Internet

https://www.frontiersin.org/articles/10.3389/ftox.2023.1113032/full

Similar Items